~/ To properly diagnose and treat the Chiari I malformation, it is necessary to know: 1) the position of the cerebellar tonsils; 2) the degree of compressiop of the upper cervical cord and medulla; 3) the status of the spinal cord, particularly whether a syringohydromyelic condition exists; 4) whether basal arachnoiditis is present; 5) the nature of the communication between the fourth ventricle and the subarachnoid space; and 6) the overall ventricular size. The use of computerized tomography (CT) alone is not sufficient to furnish all of this information. The addition of metrizamide to the CT study enables the exact delineation of the basic pathology of the Chiari I malformation and its associated complications. A total of seven patients with surgically proven Chiari I malformation were included in this study. In all of these cases, CT with metrizamide was the essential diagnostic procedure. Plain films appear to be necessary only to facilitate the diagnosis of an associated Klippel-Feil syndrome or scoliosis.
T
HE Chiari I malformation consists of variable downward displacement of the cerebellar tonsils without an associated myelomeningocele. 7, 8 In some cases, cervical spine anomalies may be present.' Syringohydromyelia may occur as a result of poor fourth ventricular outflow; significant ventricular enlargement is rare2 , 4 Prior to the introduction of computerized tomography (CT), the neuroradiological evaluation of this condition at our institution usually consisted of cerebral angiography to assess ventricular size and the position of the cerebellar tonsils, as well as to exclude a mass lesion in the area of the foramen magnum) ,'~ This was followed by Pantopaque or air myelography. If the ventricles were found to be enlarged at angiography, ventriculography was occasionally the secondary procedure of choice. It was hoped that, with the introduction of CT, the exact delineation of the pathology could be realized. However, with most of the present generation of scanners, it is not possible to delineate with certainty the tissue below the level of the foramen magnum nor the size and consistency of the spinal cord. 6 Metrizamide myelography combined with CT allows an accurate assessment of all the parameters to diagnose and plan treatment of the Chiari I malformation. We wish to present our experience with seven patients, all of whom underwent metrizamide CT followed by operative confirmation of this disorder.
Clinical Material and Methods
All patients had a routine enhanced study of the upper cervical spine and head, using a 20/10 Delta scanner. This was then followed with cervical and cranial CT after the subarachnoid introduction of metrizamide. Metrizamide was used in two ways. Several of the patients had a formal cervical myelogram, performed with 10 cc of a 250 mg I/cc concentration of metrizamide. The myelogram was performed via a lumbar puncture using the technique of Fox, et al. 2 After the filming of the cervical area in a prone and supine position, the patient was placed in a 30 ~ upright position for 2 hours and then scanned in the supine position. This obviated the complication of seizures and mental status changes which can result from too high a dose of metrizamide reaching the brain.
The other group of patients were given 5 cc of a 190 mg I/cc concentration of metrizamide via lumbar puncture. They were then placed prone in a 45 ~ Trendelenburg position for 45 seconds, then in a 45 ~ Trendelenburg supine position for 45 seconds, after which they were immediately scanned in the supine position. In one patient an enlarged cord was noted at myelography, and an immediate CT scan and a delayed scan 3 hours later were performed. Scans were performed every centimeter through the lower cervical cord, every 4 mm through the upper cervical cord and posterior fossa, and every centimeter through the head after the introduction of metrizamide.
Results
T a b l e 1 gives the clinical history a n d T a b l e 2 the most p e r t i n e n t radiological findings in o u r seven patients. E m p h a s i s in i n t e r p r e t a t i o n o f the scans was placed o n the size a n d shape of the cervical cord, the position o f the cerebellar tonsils, the position a n d filling of the fourth ventricle, v e n t r i c u l a r size, a n d the patency of the basal cisterns. Figures 1 to 4 demonstrate the salient findings in a number of the cases. As is noted in Table 2 , one patient had a cervical spine anomaly and a second had scoliosis. Abnormal cervical cords were found in three patients, two with syringohydromyelia, and one with atrophy. All had signs and symptoms of cord involvement. The other four patients whose cords appeared normal presented with ataxic gait, thought to be due to compression at the foramen magnum. None of the patients required other invasive neuroradiological procedures, nor did any significant complications occur.
Discussion
With the introduction of metrizamide myelocisternography, it is now possible to evaluate all aspects of the Chiari I malformation with a single procedure. The exact position of the cerebellar tonsils and their relationship to the upper cervical cord and medulla can be ascertained. Their continuity with the cerebellar hemispheres and their morphology excludes other masses in this area, such as neurofibroma and meningioma. The status of the cervical cord can be appraised. Syringohydromyelia has a varied appearance on metrizamide CT scans. According to some authors, an atrophic cord with a flattened ventral border is the most common manifestation? In our limited experience, an expanded cord with a low-density center has been the most common observation. Metrizamide has the added value, as shown in Case 6 ( Fig. 3 lower  right) , of often penetrating into the cyst and further showing that the expanded cord is due to a cystic lesion rather than a tumor. Whether this would be a normal yes C-2 normal C-2 normal C-2 normal C-3 normal platybasia, basilar impression, occipitalization of C-1, fusion C-2, C-3 C-1 enlarged C-2 enlarged delayed entry of metrizamide into cord, scoliosis C-2 small * Entry of metrizamide into the fourth ventricle and basilar cistern. constant observation in cystic spinal cords is unknown. The atrophic cord is more o f a problem. Our one case o f a small cord (Fig. 4) did have the appearance described by Resj6, et al., ~ of the atrophic cord of advanced syringohydromyelia, but at surgery a syrinx was not found. In all o f our cases, metrizamide entered the fourth ventricle and the basal cisterns, excluding a significant basal arachnoiditis which according to Williams 9 is a poor prognostic sign for surgical treatment o f the Chiari malformation.
We believe that C T scanning followed by a metrizamide-assisted C T scan is the primary neuroradiological diagnostic tool in the evaluation o f the Chiari I malformation. M a n y patients with this malformation will have only subjective complaints, especially early in their disease process. Previously, these patients could only be evaluated with multiple costly invasive procedures. W h e n the index o f suspicion is high, metrizamide myelocisternography with C T will confirm the diagnosis with less burden to the patient, both physically and financially.
